Recommendations for Quicker CTA Negotiation
Whether in Canada or any other country it is no secret that executing Clinical Trial Agreements (CTAs) is often the…
Overcome Today’s New Enrollment Challenges
Choose Your Specialized CRO Partner Well The global clinical trials market is expected to reach $69.8 billion US by 2027,…
Collaborative Vendor Teaming for Better Oncology Trial Results – Real World Evidence
Workplace collaboration requires a willingness to find solutions to problems, together with others. Which means that any successful collaborative vendor…
Overcome Oncology Clinical Trial Obstacles – 2019 Real World Evidence for 2020 and Beyond
Overall the clinical trial market is growing at a robust pace that is expected to continue into 2024, owing to…
Going Above-and-Beyond – What Can Your Specialized Oncology CRO Do for You?
Clinical research is a growing and fascinating field marked by increasing complexity and competitive surroundings. CROs can help their Sponsors…
Oncology Trial Investigators and Participants – Where to Look?
Global Leaders in Number of Clinical Trial Participants Today Clinical research is becoming more complex, with more clinical trials than…
Hassle-Free Site Selection and Study Start-up for Clinical Trials in Canada
It is no secret that Canada’s presence as a key player in the field of pharmaceutical drug development is rapidly…
Do You Believe the Myths About Conducting Clinical Trials in Canada?
Myths exist to explain things we don’t understand, as well as to continue traditions and keep relationships and societies ‘safe’.…
What is Most Important When Conducting Oncology Clinical Research in Canada?
Developing oncology compounds is a constantly evolving process, and with the dramatic rise in costs, and competitive trials, making every…
Your Specialized Oncology CRO as Strategic Advisor – Real World Evidence
Optimizing the partnership between Sponsors and CROs can move the relationship from a tactical client/vendor operating model to a more…